Adaptive Biotechnologies (NASDAQ: ADPT)
Adaptive Biotechnologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Adaptive Biotechnologies Company Info
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
News & Analysis
Why Adaptive Biotechnologies Topped the Market Today
A double beat on earnings, plus positive adjustments to certain guidance items, lifted the company's shares.
Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You?
The Ark Invest founder sees potential in these three under-the-radar stocks.
Why Shares of Adaptive Biotechnologies Corporation Jumped This Week
The company could see its first FDA-approved therapy as early as next year.
ASCO 2022: Surprising News in Cancer Research
The American Society of Clinical Oncology (ASCO) just finished up its annual meeting. We have some winners coming out of the conference.
10 Amazing Stocks Under $10 (Part II)
Because of this stock market crash, some wonderful stocks are super cheap in 2022. Here's a mini-portfolio of innovative companies trading under $10 a share right now.
Cathie Wood Can't Get Enough of These 2 Biotech Stocks
The CEO of Ark Invest hasn't given up on these risky biotech stocks.
3 Life Science Stocks Cathy Wood's Buying Hand Over Fist Right Now
ARK Invest made multiple purchases of these stocks last week.
5 Under-the-Radar Tickers That Will Stomp the Market in 2021
Investors are hyper-focused on COVID-19 right now, but once vaccines for the virus have been approved, other healthcare stocks will start to zoom forward.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.